Literature DB >> 11571929

Growth hormone and sex steroids. Interactions in puberty.

N Mauras1.   

Abstract

Dynamic interactions among growth hormone, IGF-1, and sex steroidal hormones have a major role in the achievement of full height potential and the body composition changes in adolescence. Testosterone and estrogen affect the growth hormone neuroendocrine rhythms, and growth hormone, in turn, potentiates many of the metabolic actions of the sex steroids. Leptin is also thought to have a key regulatory role in the process of sexual development in the child, but the precise nature of these interactions is unclear. The targeted replacement of hormonal deficiencies in puberty and manipulation of the timing of pubertal maturation have resulted in better strategies to treat profoundly short children during this period; however, more research is needed to determine the consequences of such approaches in aspects of metabolism other than linear growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571929     DOI: 10.1016/s0889-8529(05)70200-0

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

Review 1.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

2.  Pubertal growth and adult height in relation to breast cancer risk in African American women.

Authors:  Kimberly A Bertrand; Hanna Gerlovin; Traci N Bethea; Julie R Palmer
Journal:  Int J Cancer       Date:  2017-09-13       Impact factor: 7.396

Review 3.  The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice.

Authors:  Lisa E Olson; Claes Ohlsson; Subburaman Mohan
Journal:  Calcif Tissue Int       Date:  2010-11-27       Impact factor: 4.333

Review 4.  Obesity and the pubertal transition in girls and boys.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Reproduction       Date:  2010-09       Impact factor: 3.906

5.  Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.

Authors:  D Micić; M Sumarac-Dumanović; Dj Macut; A Kendereski; S Zoric; V Popović; G Cvijović; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 6.  Growth hormone receptor modulators.

Authors:  Vita Birzniece; Akira Sata; Ken K Y Ho
Journal:  Rev Endocr Metab Disord       Date:  2009-06       Impact factor: 6.514

7.  Association of BMI with Linear Growth and Pubertal Development.

Authors:  Izzuddin M Aris; Sheryl L Rifas-Shiman; Xun Zhang; Seungmi Yang; Karen Switkowski; Abby F Fleisch; Marie-France Hivert; Richard M Martin; Michael S Kramer; Emily Oken
Journal:  Obesity (Silver Spring)       Date:  2019-09-03       Impact factor: 5.002

8.  Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle protein synthesis or intracellular signalling in young men.

Authors:  Daniel W D West; Gregory W Kujbida; Daniel R Moore; Philip Atherton; Nicholas A Burd; Jan P Padzik; Michael De Lisio; Jason E Tang; Gianni Parise; Michael J Rennie; Steven K Baker; Stuart M Phillips
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

9.  Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors.

Authors:  Daniel W D West; Nicholas A Burd; Jason E Tang; Daniel R Moore; Aaron W Staples; Andrew M Holwerda; Steven K Baker; Stuart M Phillips
Journal:  J Appl Physiol (1985)       Date:  2009-11-12

Review 10.  Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.

Authors:  Zhongbo Liu; Subburaman Mohan; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2015-12-31       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.